Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ritchie, A.
Right arrow Articles by Broxmeyer, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ritchie, A.
Right arrow Articles by Broxmeyer, H. E.
Stem Cells, Vol. 14, No. 3, 330-336, May 1996
© 1996 AlphaMed Press

ORIGINAL PAPER

Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor-Dependent Cell Line, M07e

Alec Ritchiea, Saroj Vadhan-Rajd, Hal E. Broxmeyera,b,c

a Departments of Microbiology/Immunology,
b Medicine, and
c the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN, USA, and
d the MD Anderson Cancer Center, Houston, TX, USA

Key Words. M07e • Thrombopoietin • Survival factors • Growth factors • Apoptosis

Dr. Hal E. Broxmeyer, Walther Oncology Center, Indiana University School of Medicine, 975 W. Walnut Street, Indianapolis, IN 46202-5121, USA.

Thrombopoietin (TPO) has been demonstrated to have proliferative effects on hematopoietic progenitor cells and maturational effects on more committed populations which express a megakaryocyte lineage-specific phenotype. M07e is a GM-CSF or interleukin 3 (IL-3)-dependent human leukemic cell line having surface markers characteristic of both myeloid progenitors and megakaryocytes. The effects of TPO on the proliferation and survival of M07e cells were investigated. Following an 18-h factor starvation period to remove residual growth factor signals and phase the cells in G0/G1, TPO provides a weak proliferative signal to M07e compared to IL-3 or GM-CSF treatment under the same conditions. However, TPO synergizes with both GM-CSF and IL-3, and to a greater extent with steel factor, a competence factor for M07e, in the induction of cellular proliferation. TPO sustains cellular integrity of M07e during prolonged (18 days) growth factor withdrawal and also protects M07e cells in serum-free conditions. In addition, preincubation of M07e for 72 h in TPO maintains its survival for subsequent cytokine-induced proliferation, while control media do not. TPO suppresses growth factor withdrawal-induced apoptosis as evaluated by flow cytometric detection of both in situ terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling and cellular DNA content via propidium iodide staining. These results suggest a role for TPO as a survival factor for M07e cells.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
P. G. Fuhrken, P. A. Apostolidis, S. Lindsey, W. M. Miller, and E. T. Papoutsakis
Tumor Suppressor Protein p53 Regulates Megakaryocytic Polyploidization and Apoptosis
J. Biol. Chem., June 6, 2008; 283(23): 15589 - 15600.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
K. Heo, U. Jariwala, J. Woo, Y. Zhan, K. A. Burke, L. Zhu, W. F. Anderson, and Y. Zhao
Involvement of Niemann-Pick Type C2 Protein in Hematopoiesis Regulation
Stem Cells, June 1, 2006; 24(6): 1549 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Vadhan-Raj, S. Patel, C. Bueso-Ramos, J. Folloder, N. Papadopolous, A. Burgess, L. D. Broemeling, H. E. Broxmeyer, and R. S. Benjamin
Importance of Predosing of Recombinant Human Thrombopoietin to Reduce Chemotherapy-Induced Early Thrombocytopenia
J. Clin. Oncol., August 15, 2003; 21(16): 3158 - 3167.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
N. Dainiak, J. K. Waselenko, J. O. Armitage, T. J. MacVittie, and A. M. Farese
The Hematologist and Radiation Casualties
Hematology, January 1, 2003; 2003(1): 473 - 496.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Lee, A. Gotoh, H.-J. Kwon, M. You, L. Kohli, C. Mantel, S. Cooper, G. Hangoc, K. Miyazawa, K. Ohyashiki, et al.
Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines
Blood, May 29, 2002; 99(12): 4307 - 4317.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Kirito, T. Watanabe, K.-i. Sawada, H. Endo, K. Ozawa, and N. Komatsu
Thrombopoietin Regulates Bcl-xL Gene Expression through Stat5 and Phosphatidylinositol 3-Kinase Activation Pathways
J. Biol. Chem., March 1, 2002; 277(10): 8329 - 8337.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
M Nazareth, P Fanti, C Schwach, K Poppenberg, K Janis, and S M Aronica
Altered Bax expression and decreased apoptosis in bone marrow cells of lupus-susceptible NZB/W mice
Lupus, November 1, 2001; 10(11): 785 - 793.
[Abstract] [PDF]

Home page
 Stem CellsHome page
A. M. Farese, W. G. Smith, J. G. Giri, N. Siegel, J. P. McKearn, and T. J. MacVittie
Promegapoietin-1a, an Engineered Chimeric IL-3 and Mpl-L Receptor Agonist, Stimulates Hematopoietic Recovery in Conventional and Abbreviated Schedules Following Radiation-Induced Myelosuppression in Nonhuman Primates
Stem Cells, July 1, 2001; 19(4): 329 - 338.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Battinelli and J. Loscalzo
Nitric oxide induces apoptosis in megakaryocytic cell lines
Blood, June 1, 2000; 95(11): 3451 - 3459.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
S M Aronica, A Dozier, P Fanti, and M Nazareth
Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin
Lupus, May 1, 2000; 9(4): 271 - 277.
[Abstract] [PDF]

Home page
 BloodHome page
Y. Hong, D. Dumenil, B. van der Loo, F. Goncalves, W. Vainchenker, and J. D. Erusalimsky
Protein Kinase C Mediates the Mitogenic Action of Thrombopoietin in c-Mpl-Expressing UT-7 Cells
Blood, February 1, 1998; 91(3): 813 - 822.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Shibuya, H. Akahori, K. Takahashi, E. Tahara, T. Kato, and H. Miyazaki
Multilineage Hematopoietic Recovery by a Single Injection of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Myelosuppressed Mice
Blood, January 1, 1998; 91(1): 37 - 45.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Ritchie, A. Gotoh, J. Gaddy, S. E. Braun, and H. E. Broxmeyer
Thrombopoietin Upregulates the Promoter Conformation of p53 in a Proliferation-Independent Manner Coincident With a Decreased Expression of Bax: Potential Mechanisms for Survival Enhancing Effects
Blood, December 1, 1997; 90(11): 4394 - 4402.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. J. Borge, V. Ramsfjell, L. Cui, and S. E.W. Jacobsen
Ability of Early Acting Cytokines to Directly Promote Survival and Suppress Apoptosis of Human Primitive CD34+CD38- Bone Marrow Cells With Multilineage Potential at the Single-Cell Level: Key Role of Thrombopoietin
Blood, September 15, 1997; 90(6): 2282 - 2292.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
H. J. Kim, Y. Okamoto, M. Ito, Y. Takaue, Y. Kawano, T. Watanabe, T. Yamaue, Y. Tohda, T. Ogose, T. Shimada, et al.
Evaluation of a Cytokine Combination Including Thrombopoietin for Improved Transduction of a Retroviral Gene into G-CSF-Mobilized CD34+ Human Blood Cells
Stem Cells, September 1, 1997; 15(5): 347 - 352.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 1996 by AlphaMed Press.